UPDATE 1-Merck hit with $285,000 verdict in Fosamax trial NEW YORK, Feb 5 (Reuters) - A federal jury on Tuesdayordered Merck & Co Inc to pay $285,000 in a lawsuit overthe risks of its osteoporosis drug Fosamax , the second loss forthe company after several earlier trials. The eight-person jury in U.S. District Court in Manhattanfound that Merck failed to warn plaintiff Rhoda Scheinberg'sdoctors of the risks associated with Fosamax . The jury rejectedthe ... [News Source]